A new study from the McGovern Institute suggest “that one of the most effective ways to stimulate children’s brains from a young age is back-and-forth conversation,” writes Elise Takaham for The Boston Globe. “We think that it’s because back-and-forth conversation is not only about hearing more words, it’s also about practicing paying attention to someone else and involves lots of emotional and social bonding,” said Prof. John Gabrieli.
A study by MIT scientists has identified the neurons that fire at the beginning and end of activities, which is important for initiating a routine. “This task-bracketing appears to be important for initiating a routine and then notifying the brain once it is complete,” Prof. Ann Graybiel told Xinhua.
Boston Herald reporter Lindsay Kalter writes that a team of MIT researchers has developed a new technique that can deliver medication to specific regions of the brain with extreme precision. “The whole idea here is that instead of treating the entire brain, you can treat small portions of the brain,” explains Prof. Michael Cima.
AP reporter Lauran Neergaard writes that MIT researchers have developed a hair-thin implant that can deliver medications to specific regions of the brain. Neergaard writes that the device, “could mark a new approach to treating brain diseases — potentially reducing side effects by targeting only the hard-to-reach circuits that need care.”
MIT researchers have developed a new capsule that allows HIV medication to be delivered over the course of a week, and could allow patients to forgo daily pills, reports Ed Cara for Gizmodo. Researchers also found that using this method for the pre-exposure pill, “would manifest in approximately a 20 per cent increase in efficacy” for weekly dosage compared to the daily regimen.
HuffPost reporter Sophie Gallagher writes that MIT researchers have developed a new capsule that would allow patients to take a week’s worth of HIV medications in one dose. The researchers believe that, “the innovation could improve the efficacy of HIV preventative treatment by approximately 20%.”
MIT researchers have developed a new slow-release capsule that could free HIV patients from having to take a daily dose of medication, according to the BBC. “Changing a medication so it only needs to be taken once a week rather than once a day should be more convenient and improve compliance,” explains research affiliate Giovanni Traverso.
UPI reporter Alan Mozes writes that MIT researchers have developed a new capsule that could be used to deliver a week’s worth of HIV medications in a single dose. “The new pill sits in the stomach for a full week, as each of seven pill compartments opens up, one-by-one, to deliver a 24-hour dose of three HAART drugs,” Mozes explains.
MIT researchers have developed a new technique to 3-D print genetically engineered bacteria into a variety of shapes and forms, reports Karen Hao for Quartz. The technique could eventually be used to develop such devices as, “an ingestible living robot that secretes the correct drug when it detects a tumor.”
MIT engineers have developed a method to 3-D print living cells into tattoos and 3-D structures, reports Danny Paez for Inverse. Paez explains that the researchers believe the technique, “could possibly be used to create a ‘living computer,’ or a structure made up of living cells that can do the stuff your laptop can.”
Co.Design reporter Katharine Schwab writes that MIT researchers have developed a tattoo made of living cells that activate when exposed to different kinds of stimuli. Schwab explains that in the future the tattoos could be designed, “so that they respond to environmental pollutants or changes in temperature.”
A new study by MIT researchers shows how stress can lead people to make risky decisions, reports Kristin Hugo for Newsweek. “The study lends insights into how neurological disorders affect people. It could be the stress of dealing with inabilities to function properly and staving off cravings, compounded with the chemical effects on the brain, that are influencing people’s uninhibited behavior.”
Using nanotechnology and CRISPR, Prof. Daniel Anderson has turned off a cholesterol-related gene in mouse liver cells, reports Julie Steenhuysen for Reuters. This new development “could lead to new ways to correct genes that cause high cholesterol and other liver diseases,” Steenhuysen writes.
After studying more than 100 languages, Prof. Edward Gibson has “discovered a pattern in the way different cultures discern and label colors,” writes Ben Thompson for the Boston Globe.
A new study from Prof. Edward Gibson examines the way different languages describe colors. “If you were to take the spectrum of colors that are perceptibly different to humans and chop it in half, every language would have more words for describing the warm half than the cool half,” writes Rachel Gutman for The Atlantic.